Found: 9
Select item for more details and to access through your institution.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of radiochemotherapy on peripheral immune response in glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03722-5
- By:
- Publication type:
- Article
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2549, doi. 10.1007/s00262-022-03182-9
- By:
- Publication type:
- Article
Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2637, doi. 10.3390/cancers12092637
- By:
- Publication type:
- Article
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1429, doi. 10.3390/cancers12061429
- By:
- Publication type:
- Article
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11534-6
- By:
- Publication type:
- Article
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02732-5
- By:
- Publication type:
- Article
IRF8-dependent molecular complexes control the Th9 transcriptional program.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01070-w
- By:
- Publication type:
- Article
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1437961
- By:
- Publication type:
- Article